Status:
UNKNOWN
Antimicrobial Susceptibility for Helicobacter Pylori Eradication
Lead Sponsor:
Hospital Donostia
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
18-80 years
Brief Summary
Due to the high rate of resistance to clarithromycin in our area the investigators proposed an study to assess the need of antibiogram previous to the empirical OCA 10 treatment, in order to improve t...
Detailed Description
Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori PURPOSE Background: * The rate of eradication of Helicobacter pylori with standard triple therapy (OCA: omeprazo...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of H. pylori infection provided by culture, histology or UBT.
- Patients need and indication to treat (peptic ulcer disease, firs-degree family history of gastric cancer, MALT lymphoma or dyspeptic symptoms)
- Patients must be 18 years or older.
- Exclusion criteria:
- Previous treatment for H. pylori eradication.
- Patients who have severe concomitant disease.
- Patients who have previous gastric surgery.
- Patients who have intolerance to any antimicrobial drugs.
Exclusion
Key Trial Info
Start Date :
February 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2012
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01486082
Start Date
February 1 2011
End Date
May 1 2012
Last Update
December 13 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Donostia
Donostia / San Sebastian, Guipuzcoa, Spain, 20014